Obtaining patient perspectives during open-label extension trials.
Aarthi Iyer
Advertisement
Articles by Aarthi Iyer
Obtaining Patient Perspectives During Open Label Extension Trials
Published: | Updated:
Getting patient insights before launch is more feasible than you might think.
Advertisement
Latest Updated Articles
Obtaining Patient Perspectives During Open Label Extension TrialsPublished: June 18th 2019 | Updated: November 15th 2020
The Feasibility of Patient Insights Before LaunchPublished: July 16th 2019 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5